Skip to content
Disclosery

KINNEVIK AB (PUBL)

Follow

13F filer, CIK 1766574, STOCKHOLM, Sweden

KINNEVIK AB (PUBL) reported $102,599,886 across 1 holding for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-02.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-010045

Period
2023-12-31
Reported value
$103M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0001104659-24-010045, largest first. % of portfolio is the value over $102,599,886, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 10,405,668 shares 10,405,668$103M100%0Timeline

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-010045 base2024-02-02acceptance time not in the bulk data set